⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FHTX News
Foghorn Therapeutics Inc. Common Stock
Opioid Related Disorder Drug Pipeline and Clinical Trials Analysis Report | Long-Acting Therapies, Biologics, and Non-Opioid Innovation Drive Growth
globenewswire.com
BIIB
JAZZ
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
globenewswire.com
FHTX
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Foghorn Therapeutics Inc. (FHTX) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
accessnewswire.com
FHTX
FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law
businesswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
accessnewswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
accessnewswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
accessnewswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
prnewswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
accessnewswire.com
FHTX